MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$40,863K
Net Income
-$23,474K
Net Profit Margin
-57.45%
EPS
-$0.43
Unit: Thousand (K) dollars
Revenue Breakdown
Product
Partnership And Other Revenue
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-07-31
Total revenues
40,863
26,402*
13,692
1,426
Cost of revenue
3,090
348*
1,232
590
Research and development
12,420
-7,361*
11,993
15,162
Selling, general and administrative
48,795
-12,136*
46,517
44,683
Total operating expenses
64,305
-19,150*
59,742
60,435
Operating gain
-23,442
45,552*
-46,050
-59,009
Interest income
2,548
203*
1,875
1,849
Interest expense
5,586
477*
4,757
3,522
Foreign currency exchange (gain) loss
-52
-1,531*
-884
1,925
Other income, net
3,045
3,593*
2,491
818
Total other (expense) income
-45
1,788*
-1,275
1,070
Gain before income tax expense
-23,487
47,339*
-47,325
-57,939
Income tax (benefit) expense
-
-7,504*
2,157
2,157
Net gain
-23,487
54,843*
-49,482
-60,096
Foreign currency translation gain (loss)
280
-1,464*
911
-604
Unrealized holding loss (gain) on marketable securities
-278
9*
187
18
Reclassification adjustment for realized holding (income) gain on marketable securities included in net gain
-11
-810*
771
587
Total other comprehensive income (loss)
13
-646*
327
-1,173
Comprehensive gain
-23,474
54,197
-49,155
-61,269
Basic EPS
-0.43
0.999
-0.92
-1.12
Diluted EPS
-0.43
0.999
-0.92
-1.12
Basic Average Shares
54,583,424
54,229,212
53,883,681
53,497,128
Diluted Average Shares
54,583,424
54,229,212
53,883,681
53,497,128
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Foreign currency
translation gain (loss)
$280K
Reclassification adjustment for
realized holding...
-$11K
Comprehensive gain
-$23,474K
Total other
comprehensive income (loss)
$13K
Unrealized holding loss
(gain) on marketable...
-$278K
Net gain
-$23,487K
Gain before income
tax expense
-$23,487K
Product
$39,165K
Partnership And Other
Revenue
$1,698K
Operating gain
-$23,442K
Total other (expense)
income
-$45K
Total revenues
$40,863K
Other income, net
$3,045K
Interest income
$2,548K
Total operating
expenses
$64,305K
Interest expense
$5,586K
Foreign currency
exchange (gain) loss
-$52K
Selling, general and
administrative
$48,795K
Research and development
$12,420K
Cost of revenue
$3,090K
Buy us a coffee
KalVista Pharmaceuticals, Inc. (KALV)
KalVista Pharmaceuticals, Inc. (KALV)